Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 8
Submit an article Journal homepage
2,500
Views
21
CrossRef citations to date
0
Altmetric
Research Papers

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus

Olivier Van Der MeerenEastern Clinical Research Unit, Department of Medicine, Monash University, and Eastern Health, Box Hill, Victoria, AustraliaCorrespondence[email protected]
,
James T. PetersonJ. Lewis Research, Salt Lake City, UT, USA
,
Marc DionneCentre Hospitalier Universitaire, Quebec, Canada
,
Richard BeasleyMedical Research Institute of New Zealand, Wellington, New Zealand
,
Peter R. EbelingDepartment of Medicine, School for Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia
,
Murdo FergusonColchester Research Group, Nova Scotia, Canada
,
Michael D. NissenQueensland Paediatric Infectious Diseases Laboratory, Queensland Children's Medical Research Institute, University of Queensland, Herston, Queensland, Australia;GSK Vaccines, Singapore
,
Paul RheaultMedicor Research, Sudbury, Canada
,
Richard W. SimpsonEastern Clinical Research Unit, Department of Medicine, Monash University, and Eastern Health, Box Hill, Victoria, Australia
,
Marc De RidderEastern Clinical Research Unit, Department of Medicine, Monash University, and Eastern Health, Box Hill, Victoria, Australia;Faculté de Pharmacie, Université Libre de Bruxelles, Bruxelles, Belgium
,
Priya D. CrastaGSK Pharmaceuticals Ltd., Mumbai, India
,
Jacqueline M. MillerGSK Vaccines, King of Prussia, PA, USA
&
Andrew F. TrofaGSK Vaccines, King of Prussia, PA, USA
 show all
Pages 2197-2203 | Received 13 Nov 2015, Accepted 06 Mar 2016, Published online: 28 Apr 2016

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Thomas Verstraeten, Mark A. Fletcher, Jose A. Suaya, Sally Jackson, Cassandra K. Hall-Murray, Daniel A. Scott, Beate Schmöle-Thoma, Raul E. Isturiz & Bradford D. Gessner. (2020) Diabetes mellitus as a vaccine-effect modifier: a review. Expert Review of Vaccines 19:5, pages 445-453.
Read now
Caroline Van Den Ende, Cinzia Marano, Ayla Van Ahee, Eveline M. Bunge & Laurence De Moerlooze. (2017) The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Review of Vaccines 16:8, pages 811-832.
Read now

Articles from other publishers (19)

Anne Moeser & Mathias W. Pletz. (2023) Wichtige Impfempfehlungen für Diabetiker. Info Diabetologie 17:1, pages 37-40.
Crossref
Anne Moeser & Mathias W. Pletz. (2023) Wichtige Impfempfehlungen für Diabetiker. CardioVasc 23:1, pages 48-52.
Crossref
Chi-Ho Lee, Victor Gray, Jia Ming Nickolas Teo, Anthony Raymond Tam, Carol Ho-Yi Fong, David Tak-Wai Lui, Polly Pang, Kwok Hung Chan, Ivan Fan-Ngai Hung, Kathryn Choon-Beng Tan & Guang Sheng Ling. (2022) Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines. Frontiers in Immunology 13.
Crossref
Lawrence Blonde, Guillermo E. Umpierrez, S. Sethu Reddy, Janet B. McGill, Sarah L. Berga, Michael Bush, Suchitra Chandrasekaran, Ralph A. DeFronzo, Daniel Einhorn, Rodolfo J. Galindo, Thomas W. Gardner, Rajesh Garg, W. Timothy Garvey, Irl B. Hirsch, Daniel L. Hurley, Kenneth Izuora, Mikhail Kosiborod, Darin Olson, Shailendra B. Patel, Rodica Pop-Busui, Archana R. Sadhu, Susan L. Samson, Carla Stec, William V. TamborlaneJr.Jr., Katherine R. Tuttle, Christine Twining, Adrian Vella, Priyathama Vellanki & Sandra L. Weber. (2022) American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocrine Practice 28:10, pages 923-1049.
Crossref
Leena Almasri & Barbara J. Holtzclaw. (2021) Assessing Vaccine Protection for Older Adults with Diabetes: A Systematic Review. Western Journal of Nursing Research 44:6, pages 582-597.
Crossref
Joseph J. Alukal, Haider A. Naqvi & Paul J. Thuluvath. (2022) Vaccination in Chronic Liver Disease: An Update. Journal of Clinical and Experimental Hepatology 12:3, pages 937-947.
Crossref
M. V. Shestakova, T. V. Nikonova, V. O. Barysheva & N. G. Mokrysheva. (2022) Vaccination of patients with diabetes mellitus. Diabetes mellitus 25:1, pages 50-60.
Crossref
Elena V Esaulenko, Aleksey A Yakovlev, Genady A Volkov, Anastasia A Sukhoruk, Kirill G Surkov, Peter V Kruglyakov & Francisco Diaz-Mitoma. (2021) Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation. Clinical Infectious Diseases 73:9, pages e3333-e3339.
Crossref
Bingfeng Han, Wu Liu, Juan Du, Hanyu Liu, Tianshuo Zhao, Shubo Yang, Shuai Wang, Sihui Zhang, Bei Liu, Yaqiong Liu & Fuqiang Cui. (2021) Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial. Vaccine 39:25, pages 3365-3371.
Crossref
Waseem Amjad, Joseph Alukal, Talan Zhang, Anurag Maheshwari & Paul J. Thuluvath. (2020) Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease. Digestive Diseases and Sciences 66:6, pages 2101-2106.
Crossref
Shivali S. Joshi, Rachelle P. Davis, Mang M. Ma, Edward Tam, Curtis L. Cooper, Alnoor Ramji, Erin M. Kelly, Saumya Jayakumar, Mark G. Swain, Craig N. Jenne & Carla S. Coffin. (2021) Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD). npj Vaccines 6:1.
Crossref
José L. Bravo-Grande, M. Asunción Blanco-González, José M. de la Torre-Robles, Marita P. Asmat-Inostrosa, Marina Fernández-Escribano, Itria Mirabella Villalobos, M. Covadonga Caso-Pita, Marina Hervella-Ordoñez, Luis M. Cañibano Cimas, José M. de la Fuente-Martín, M. Luisa Rodríguez de la Pinta, Jenry Ricardo Borda Olivas, Carmen Muñóz-Ruipérez, Miguel A. Alonso López, MT del Campo, M. Antonieta Ramírez Pérez, Ignacio Sánchez-Arcilla, Marco Marzola-Payares, Fernando Rescalvo-Santiago, Miguel de Paula-Ortiz, José M. Sánchez-Santos & Ricardo López-Pérez. (2021) Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines. Vaccine 39:3, pages 554-563.
Crossref
Elizabeth M. Rosenthal, Eric W. Hall, Eli S. Rosenberg, Aaron Harris, Noele P. Nelson & Sarah Schillie. (2020) Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations. Vaccine 38:51, pages 8206-8215.
Crossref
Servet ÖZTÜRK, Merve KAÇAR, Semra TOPRAK, Onur ÇOLAK, Derya ÖZTÜRK & Canan AGALAR. (2020) Hepatit B Aşılama Verileri; İmmünsüpresif Hastalarda Tek Doz mu? Çift Doz mu?. Namık Kemal Tıp Dergisi.
Crossref
Ariane Sultan, Bernard Bauduceau, Sabine Baron, Sophie Brunot, Ludovic Casanova, Claude Chaumeil, Florence Galtier, Brigitte Lecointre, Aurélie Morand, Laura Phirmis, Brigitte Sallerin, Benoît de Wazières & Benjamin Wyplosz. (2020) Référentiel de la Société francophone du diabète (SFD) : vaccination chez la personne diabétique. Médecine des Maladies Métaboliques 14:1, pages 46-57.
Crossref
Randall N. Hyer & Robert S. Janssen. (2019) Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years. Vaccine 37:39, pages 5854-5861.
Crossref
Carolyn B. Bridges, Tureka L. Watson, Noele P. Nelson, Maribel Chavez-Torres, Patrick Fineis, Boatemaa Ntiri-Reid, Edward Wake, Judith M. Leahy, Anita K. Kurian, Mary Ann K. Hall & Erin D. Kennedy. (2019) Challenges with hepatitis B vaccination of high risk adults – A pilot program. Vaccine 37:35, pages 5111-5120.
Crossref
Kaatje Bollaerts, Maria Alexandridou & Thomas Verstraeten. (2019) Risk factors for modified vaccine effectiveness of the live attenuated zoster vaccine among the elderly in England. Vaccine: X 1, pages 100007.
Crossref
Susanna Dunachie & Parinya Chamnan. (2019) The double burden of diabetes and global infection in low and middle-income countries. Transactions of The Royal Society of Tropical Medicine and Hygiene 113:2, pages 56-64.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.